ArticlePloS one2025
Association between COVID-19 vaccination, SARS-CoV-2 variants, and post COVID-19 condition: A cross-sectional study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Post-Exertional Malaise in Post-COVID-19 Syndrome: A Shift in the Frequency Across Pandemic Phases.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndividuals may experience persistent symptoms after recovering from coronavirus disease 2019 (COVID-19), a condition referred to as post COVID-19 condition (PCC). Patient-reported outcome measures (PROMs) evaluate a patient's health status and can be used to quantify symptom severity from the patient's perspective. The impact of COVID-19 vaccination and variant of infection on PCC is not well understood. We therefore sought to explore vaccination and variant trends among individuals with PCC and investigate their association with abnormal PROMs.
methodsPatients seen at Post-COVID-19 Clinics across British Columbia, Canada between March 2020 - Oct 2022 were included in the study. Those who had persistent symptoms, at least one abnormal PROM, and completed a baseline questionnaire within 6 months of infection were included. The following PROMs were used: Fatigue Severity Score, University of California San Diego Shortness of Breath Questionnaire, Post Traumatic Stress Disorder (PTSD) Score, Generalized Anxiety Disorder-2 and Patient Health Questionnaire-2. Vaccination status was categorized based on the number and timing of vaccinations relative to SARS-CoV-2 infection. Logistic regression was used to evaluate the association between COVID-19 vaccination status or SARS-CoV-2 variant and the likelihood of reporting abnormal PROMs.
resultsThe study included 1,587 participants (mean age 52 ± 15 years, 45% male, 58% vaccinated). In the adjusted models, full vaccination among non-hospitalized patients was associated with a reduced likelihood of reporting PTSD. Hospitalized patients infected with the alpha and delta variants were more likely to report dyspnea, while those infected with the gamma variant were less likely to report PTSD.
conclusionsPatients who were partially or fully vaccinated did not have increased risk of reporting common PCC symptoms. Infection with the alpha and delta variants was associated with increased likelihood of reporting dyspnea, which may be related to the severity of acute illness and associated impairments in lung function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.